Dubey Suneeta, Shakya Rakesh, Pegu Julie, Ahluwalia Navjot, Bansal Tanima, Bhadauria Madhu, Chauhan Lokesh, Nischal Ken
Glaucoma, Dr. Shroff's Charity Eye Hospital, New Delhi, IND.
Ophthalmology, Sadguru Netra Chikitsalaya, Shri Sadguru Seva Sangh Trust, Chitrakoot, IND.
Cureus. 2025 Aug 13;17(8):e89972. doi: 10.7759/cureus.89972. eCollection 2025 Aug.
Introduction Vernal keratoconjunctivitis (VKC) is a chronic allergic condition of the eye that often requires long-term steroid use for symptom control. However, prolonged or unsupervised steroid use can lead to serious complications like steroid-induced ocular hypertension (SIOHT) and steroid-induced glaucoma (SIG). Identifying patients at risk for these complications is crucial for timely intervention and preserving vision. Objectives This study aims to (1) identify and evaluate both steroid-related and non-steroid-related risk factors associated with SIOHT and SIG in patients with VKC and (2) compare clinical characteristics, including the type of steroid used, duration of use, and visual outcomes such as need for surgery and vision loss. Additionally, the study explores differences between urban and rural populations in terms of disease presentation, management, and outcomes. Methods A multicentric retrospective proforma-driven chart review conducted in four centers from April 2019 to March 2020 analyzed patient records for steroid use, urban/rural settings, family history of glaucoma, allergies, clinical features, and treatments. Results In a study of 2,360 VKC patients, 4.7% exhibited SIOHT and/or SIG. SIG and SIOHT prevalence was 53.5% and 46.5%, with mean presentation ages of 17.1 ± 5.9 and 16.4 ± 6.0 years, respectively. Topical dexamethasone (50%) was the most used steroid. Urban-rural disparities in age and steroid usage were significant. Successful management involved steroid withdrawal (10.3% eyes), anti-glaucoma medications (62.9% eyes), and surgery (24.9% eyes). Urban areas showed higher limbal VKC rates (23%) than rural areas (7.9%) (p = 0.01). Myopia was observed in 26.5% of SIG/SIOHT eyes, while hyperopia was observed in 2.8% of cases. Additionally, 29 rural and 11 urban patients had a history of allergy (p = 0.1). The findings highlight demographic variations, steroid implications, and management strategies in VKC patients with SIG and SIOHT. Conclusion The study highlights the significant impact of glaucoma in VKC patients, revealing that 25% require surgery. Urban areas show higher limbal VKC rates, possibly linked to air pollution. Surprisingly, even milder steroids may induce SIG and SIOHT. The results have broad relevance, as they stem from the genetic and anthropological traits of North Indian populations.
引言
春季角结膜炎(VKC)是一种眼部慢性过敏性疾病,通常需要长期使用类固醇来控制症状。然而,长期或无监督地使用类固醇会导致严重并发症,如类固醇性高眼压(SIOHT)和类固醇性青光眼(SIG)。识别有这些并发症风险的患者对于及时干预和保护视力至关重要。
目的
本研究旨在(1)识别和评估与VKC患者SIOHT和SIG相关的类固醇相关和非类固醇相关风险因素,以及(2)比较临床特征,包括所用类固醇的类型、使用持续时间以及诸如手术需求和视力丧失等视力结果。此外,该研究还探讨了城市和农村人口在疾病表现、管理和结果方面的差异。
方法
2019年4月至2020年3月在四个中心进行的一项多中心回顾性表格驱动图表审查分析了患者的类固醇使用、城市/农村环境、青光眼家族史、过敏、临床特征和治疗的记录。
结果
在一项对2360例VKC患者的研究中,4.7%表现出SIOHT和/或SIG。SIG和SIOHT的患病率分别为53.5%和46.5%,平均发病年龄分别为17.1±5.9岁和16.4±6.0岁。局部地塞米松(50%)是最常用的类固醇。年龄和类固醇使用方面的城乡差异显著。成功的管理包括停用类固醇(10.3%的眼睛)、抗青光眼药物(62.9%的眼睛)和手术(24.9%的眼睛)。城市地区的角膜缘VKC发生率(23%)高于农村地区(7.9%)(p = 0.01)。在SIG/SIOHT眼睛中,26.5%观察到近视,而2.8%的病例观察到远视。此外,29名农村患者和11名城市患者有过敏史(p = 0.1)。这些发现突出了VKC合并SIG和SIOHT患者的人口统计学差异、类固醇影响和管理策略。
结论
该研究突出了青光眼对VKC患者的重大影响,表明25%的患者需要手术。城市地区角膜缘VKC发生率较高,可能与空气污染有关。令人惊讶的是,即使是较温和的类固醇也可能诱发SIG和SIOHT。这些结果具有广泛的相关性,因为它们源于北印度人群的遗传和人类学特征。